Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection

Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection

BackgroundThe use of sorafenib in the adjuvant management of hepatocellular carcinoma (HCC) is controversial.AimTo analyze the effects of adjuvant sorafenib therapy in patients with HCC at high recurrence risk after radical resection.MethodsThis was a retrospective study of patients who underwent ra...

Full description

Bibliographic Details
Main Authors: Qingli Li, Tianqiang Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
sorafenib
adjuvant therapy
hepatectomy
survival
recurrence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.633033/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.633033/full

Similar Items